Wlodek C, Hewitt H, Kennedy C T
Department of Dermatology, Bristol Children's Hospital, Bristol, UK.
Clin Exp Dermatol. 2016 Aug;41(6):625-7. doi: 10.1111/ced.12847. Epub 2016 Apr 15.
When conventional systemic immunosuppressive treatments fail in the setting of severe eczema, unlike in psoriasis, there are limited treatment options and only anecdotal evidence to help guide clinicians. There is a growing body of evidence for the use of certain biologic agents for moderate to severe eczema. We report the youngest case to date successfully and safely treated with ustekinumab for severe refractory atopic dermatitis.
